Unknown OBSERVATIONAL NCT03050333

Efficacy and Safety of Endoscopic Resection

Sponsor: EDUARDO ALBENIZ

Conditions Endoscopic Resection Gastrointestinal Neoplasms

Updated 7 times since 2017 Last updated: Feb 9, 2017 Started: Apr 25, 2013 Primary completion: Dec 31, 2022 Completion: Dec 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03050333, this observational or N/A phase trial focuses on Endoscopic Resection and Gastrointestinal Neoplasms and remains ongoing. Sponsored by EDUARDO ALBENIZ, it has been updated 7 times since 2013, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Feb 2024 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2021 — Feb 2024 [monthly]

Recruiting
Jun 2018 — Jan 2021 [monthly]

Recruiting

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

EDUARDO ALBENIZ
Fundacion Miguel Servet

Data source: Fundacion Miguel Servet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pamplona, Spain